The briefing
NHS patients will be part of a 590-person trial in London and Bristol using AI to analyze ECGs for subtle signs of heart failure and valve disease in about two seconds. Findings presented at the European Society of Cardiology congress suggest the approach could roll out nationwide within two years if validated.
Original headline
NHS to use AI to catch undetectable heart disease ‘in blink of an eye’